TY - JOUR
T1 - Differential role of cytosolic phospholipase A2 in the invasion of brain
T2 - Microvascular endothelial cells by Escherichia coli and Listeria monocytogenes
AU - Das, Aninda
AU - Asatryan, Liana
AU - Reddy, Marpadga A.
AU - Wass, Carol A.
AU - Stins, Monique F.
AU - Joshi, Sarita
AU - Bonventre, Joseph V.
AU - Kim, Kwang Sik
N1 - Funding Information:
Financial support: National Institutes of Health (NS-26310, AI-47225, and HL-61951 to K.S.K.).
PY - 2001/9/15
Y1 - 2001/9/15
N2 - Invasion of brain microvascular endothelial cells (BMECs) is a key step in the pathogenesis of meningitis due to Escherichia coli and Listeria monocytogenes. Although host cell actin cytoskeletal rearrangements are essential in BMEC invasion by E. coli K1 and L. monocytogenes, the underlying signaling mechanisms remain unclear. This study demonstrates that host cell cytosolic phospholipase A2 (cPLA2) contributes to E. coli K1 invasion of BMECs but not to L. monocytogenes invasion of BMECs. This difference was observed with 4-bromophenacyl bromide, a nonselective PLA2 inhibitor, and arachidonyl trifluoromethyl ketone, a selective cPLA2 inhibitor, and was confirmed with BMEC derived from cPLA2 knockout mice. Activation of cPLA2 leads to generation of intracellular arachidonic acid, which is metabolized via cyclooxygenase (COX) and lipo-oxygenase (LOX) pathways into eicosanoids. COX and LOX inhibitors also significantly inhibit E. coli K1 invasion of BMECs.
AB - Invasion of brain microvascular endothelial cells (BMECs) is a key step in the pathogenesis of meningitis due to Escherichia coli and Listeria monocytogenes. Although host cell actin cytoskeletal rearrangements are essential in BMEC invasion by E. coli K1 and L. monocytogenes, the underlying signaling mechanisms remain unclear. This study demonstrates that host cell cytosolic phospholipase A2 (cPLA2) contributes to E. coli K1 invasion of BMECs but not to L. monocytogenes invasion of BMECs. This difference was observed with 4-bromophenacyl bromide, a nonselective PLA2 inhibitor, and arachidonyl trifluoromethyl ketone, a selective cPLA2 inhibitor, and was confirmed with BMEC derived from cPLA2 knockout mice. Activation of cPLA2 leads to generation of intracellular arachidonic acid, which is metabolized via cyclooxygenase (COX) and lipo-oxygenase (LOX) pathways into eicosanoids. COX and LOX inhibitors also significantly inhibit E. coli K1 invasion of BMECs.
UR - http://www.scopus.com/inward/record.url?scp=0035884581&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035884581&partnerID=8YFLogxK
U2 - 10.1086/322986
DO - 10.1086/322986
M3 - Article
C2 - 11517434
AN - SCOPUS:0035884581
SN - 0022-1899
VL - 184
SP - 732
EP - 737
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
IS - 6
ER -